Drug intelligence / Profile preview

xiaoyoujiedu

Development stage
Preclinical
Lead developer
Taizhou Hospital of Traditional Chinese Medicine
01

Overview

Xiaoyoujiedu is a Traditional Chinese Medicine (TCM) prescription currently under clinical investigation for its therapeutic potential in advanced non-small cell lung cancer (NSCLC). It is being studied in combination with PD-1 monoclonal antibody and chemotherapy, with a particular focus on its sensitization mechanism to enhance the efficacy of these conventional treatments. The name "消癌解毒方" (Xiao'ai Jiedu Fang) translates to "Cancer Elimination and Detoxification Formula," suggesting its intended properties include clearing heat, detoxifying, and inhibiting cancer growth. Research indicates that this TCM prescription may exert its anti-tumor effects by inhibiting tumor cell proliferation, inducing apoptosis, regulating the immune microenvironment, and potentially inhibiting tumor angiogenesis.

Other names
Xiaooma Jiedu prescriptionXiao'ai Jiedu prescription消癌解毒方
02

Targets

EGFR T790M (Epidermal growth factor receptor T790M mutant)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)ESR1 (ERα)

Beyond the preview

Go deeper on xiaoyoujiedu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiaoyoujiedu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call